The Indian pharmaceutical market is currently valued at $50 billion ¹. This industry is expected to experience significant growth, reaching $65 billion by 2024 and a whopping $130 billion by 2030 ¹. India is a major player in the global pharmaceutical market, ranking third in terms of volume, and is the largest provider of generic medicines, accounting for 20% of global supply by volume ¹.
India’s pharmaceutical industry is driven by several factors, including:
– Government Support: The government’s Production Linked Incentive (PLI) schemes aim to boost domestic manufacturing capacity, particularly for high-value products ¹.
– Strong Domestic Demand: India’s large population and growing healthcare needs drive demand for pharmaceuticals ¹.
– Export-Oriented: India exports pharmaceuticals to over 200 countries, with the US, Africa, and the UK being key markets ¹.
The country is also a leading supplier of vaccines, accounting for 60% of global vaccine production, and is home to more than 3,000 pharma companies with a strong network of over 10,500 manufacturing facilities ¹.
ABAC
